These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

139 related items for PubMed ID: 8395682

  • 1. Tumor-suppressive function of mutated gelsolin in ras-transformed cells.
    Müllauer L, Fujita H, Ishizaki A, Kuzumaki N.
    Oncogene; 1993 Sep; 8(9):2531-6. PubMed ID: 8395682
    [Abstract] [Full Text] [Related]

  • 2. [A study on alterations of gene expression in a flat revertant R1 from ras-oncogene transformed NIH/3T3 cells].
    Müllauer L.
    Hokkaido Igaku Zasshi; 1993 Sep; 68(5):705-16. PubMed ID: 7693563
    [Abstract] [Full Text] [Related]

  • 3. [Identification of a specific protein in flat revertant cell lines derived from ras oncogene-transformed cells].
    Fujita H.
    Hokkaido Igaku Zasshi; 1990 Mar; 65(2):210-20. PubMed ID: 2194920
    [Abstract] [Full Text] [Related]

  • 4. A specific protein, p92, detected in flat revertants derived from NIH/3T3 transformed by human activated c-Ha-ras oncogene.
    Fujita H, Suzuki H, Kuzumaki N, Müllauer L, Ogiso Y, Oda A, Ebisawa K, Sakurai T, Nonomura Y, Kijimoto-Ochiai S.
    Exp Cell Res; 1990 Jan; 186(1):115-21. PubMed ID: 2153549
    [Abstract] [Full Text] [Related]

  • 5. [Progress of research on tumor suppressor genes].
    Kuzumaki N.
    Hokkaido Igaku Zasshi; 1996 Mar; 71(2):133-7. PubMed ID: 8641669
    [Abstract] [Full Text] [Related]

  • 6. Characterization of a human MSX-2 cDNA and its fragment isolated as a transformation suppressor gene against v-Ki-ras oncogene.
    Takahashi C, Akiyama N, Matsuzaki T, Takai S, Kitayama H, Noda M.
    Oncogene; 1996 May 16; 12(10):2137-46. PubMed ID: 8668339
    [Abstract] [Full Text] [Related]

  • 7. Defining the critical gene expression changes associated with expression and suppression of the tumorigenic and metastatic phenotype in Ha-ras-transformed cloned rat embryo fibroblast cells.
    Su ZZ, Austin VN, Zimmer SG, Fisher PB.
    Oncogene; 1993 May 16; 8(5):1211-9. PubMed ID: 8479744
    [Abstract] [Full Text] [Related]

  • 8. Inhibition of oncogene-mediated transformation by ectopic expression of p21Waf1 in NIH3T3 cells.
    Michieli P, Li W, Lorenzi MV, Miki T, Zakut R, Givol D, Pierce JH.
    Oncogene; 1996 Feb 15; 12(4):775-84. PubMed ID: 8632899
    [Abstract] [Full Text] [Related]

  • 9. Suppression of transformed phenotypes of Ha-ras-transformed NIH3T3 cells by caspase-2.
    Hiwasa T, Nakagawara A.
    Biochem Biophys Res Commun; 1998 Sep 29; 250(3):741-6. PubMed ID: 9784416
    [Abstract] [Full Text] [Related]

  • 10. Human retinoblastoma gene product prevents c-Ha-ras oncogene mediated cellular transformation of mouse fibroblasts.
    Kivinen L, Pitkänen K, Laiho M.
    Oncogene; 1993 Oct 29; 8(10):2703-11. PubMed ID: 8378082
    [Abstract] [Full Text] [Related]

  • 11. Cell lines containing and expressing the human herpesvirus 6A ts gene are protected from both H-ras and BPV-1 transformation.
    Araujo JC, Doniger J, Stöppler H, Sadaie MR, Rosenthal LJ.
    Oncogene; 1997 Feb 27; 14(8):937-43. PubMed ID: 9050993
    [Abstract] [Full Text] [Related]

  • 12. Mutated Atf4 suppresses c-Ha-ras oncogene transcript levels and cellular transformation in NIH3T3 fibroblasts.
    Mielnicki LM, Hughes RG, Chevray PM, Pruitt SC.
    Biochem Biophys Res Commun; 1996 Nov 12; 228(2):586-95. PubMed ID: 8920955
    [Abstract] [Full Text] [Related]

  • 13. Elevated gelsolin and alpha-actin expression in a flat revertant R1 of Ha-ras oncogene-transformed NIH/3T3 cells.
    Müllauer L, Fujita H, Suzuki H, Katabami M, Hitomi Y, Ogiso Y, Kuzumaki N.
    Biochem Biophys Res Commun; 1990 Sep 14; 171(2):852-9. PubMed ID: 2169737
    [Abstract] [Full Text] [Related]

  • 14. Growth-inhibitory functions of a mutated gelsolin (His321) in NIH/3T3 mouse fibroblasts.
    Ishizaki A, Fujita H, Kuzumaki N.
    Exp Cell Res; 1995 Apr 14; 217(2):448-52. PubMed ID: 7698245
    [Abstract] [Full Text] [Related]

  • 15. The product of the cph oncogene is a truncated, nucleotide-binding protein that enhances cellular survival to stress.
    Velasco JA, Avila MA, Notario V.
    Oncogene; 1999 Jan 21; 18(3):689-701. PubMed ID: 9989819
    [Abstract] [Full Text] [Related]

  • 16. A mammalian severin replaces gelsolin in transformed epithelial cells.
    Folger PA, Berg WJ, DeJesus Z, Fong Y, Pardee JD.
    Cancer Res; 1999 Oct 15; 59(20):5349-55. PubMed ID: 10537319
    [Abstract] [Full Text] [Related]

  • 17. Transformation of NIH/3T3 to anchorage independence by H-ras is accompanied by loss of suppressor activity.
    Tolsma SS, Cohen JD, Ehrlich LS, Bouck NP.
    Exp Cell Res; 1993 Apr 15; 205(2):232-9. PubMed ID: 8482334
    [Abstract] [Full Text] [Related]

  • 18. Antisense DNA inhibition of tumor growth induced by c-Ha-ras oncogene in nude mice.
    Gray GD, Hernandez OM, Hebel D, Root M, Pow-Sang JM, Wickstrom E.
    Cancer Res; 1993 Feb 01; 53(3):577-80. PubMed ID: 8425190
    [Abstract] [Full Text] [Related]

  • 19. Role of the cAMP and MAPK pathways in the transformation of mouse 3T3 fibroblasts by a TSHR gene constitutively activated by point mutation.
    Du Villard JA, Wicker R, Crespo P, Russo D, Filetti S, Gutkind JS, Sarasin A, Suárez HG.
    Oncogene; 2000 Oct 05; 19(42):4896-905. PubMed ID: 11039907
    [Abstract] [Full Text] [Related]

  • 20. Rit, a non-lipid-modified Ras-related protein, transforms NIH3T3 cells without activating the ERK, JNK, p38 MAPK or PI3K/Akt pathways.
    Rusyn EV, Reynolds ER, Shao H, Grana TM, Chan TO, Andres DA, Cox AD.
    Oncogene; 2000 Sep 28; 19(41):4685-94. PubMed ID: 11032018
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.